Patents by Inventor Deron R. Herr

Deron R. Herr has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CDR REGIONS OF MONOCLONAL ANTIBODY THAT ANTAGONIZE SPHINOGOSINE 1-PHOSPHATE AND RELATED METHODS
    Publication number: 20140336365
    Abstract: Materials and method for treating cancer and screening for anti-neoplastic agents are provided. These materials and methods can include sphingosine 1-phosphate antagonists that bind to sphingosine-1 phosphate receptor subtype 3. Antibodies and aptamers that selectively bind to an epitope in the extracellular loop between transmembrane domains two and three of sphingosine-1-phosphate receptor subtype 3 are provided.
    Type: Application
    Filed: August 6, 2012
    Publication date: November 13, 2014
    Inventors: Deron R. Herr, Greg L. Harris
  • Sphingosine 1-Phosphate Antagonism
    Publication number: 20120225064
    Abstract: Materials and Method for treating cancer and screening for anti-neoplastic agents are provided. These materials and methods can include sphingosine 1-phosphate antagonists that bind to sphingosine-1 phosphate receptor subtype 3. Antibodies and aptamers that selectively bind to an epitope in the extracellular loop between transmembrane domains two and three of sphingosine-1-phosphate receptor subtype 3 are provided.
    Type: Application
    Filed: May 14, 2012
    Publication date: September 6, 2012
    Applicant: EXPRESSION DRUG DESIGNS, LLC
    Inventors: Deron R. HERR, Greg L. HARRIS
  • Sphingosine 1-phosphate antagonism
    Patent number: 8212010
    Abstract: Materials and Method for treating cancer and screening for anti-neoplastic agents are provided. These materials and methods can include sphingosine 1-phosphate antagonists that bind to sphingosine-1 phosphate receptor subtype 3. Antibodies and aptamers that selectively bind to an epitope in the extracellular loop between transmembrane domains two and three of sphingosine-1-phosphate receptor subtype 3 are provided.
    Type: Grant
    Filed: February 24, 2009
    Date of Patent: July 3, 2012
    Assignee: Expression Drug Designs, LLC
    Inventors: Deron R. Herr, Greg L. Harris
  • SPHINGOSINE 1-PHOSPHATE ANTAGONISM
    Publication number: 20090226453
    Abstract: Materials and Method for treating cancer and screening for anti-neoplastic agents are provided. These materials and methods can include sphingosine 1-phosphate antagonists that bind to sphingosine-1 phosphate receptor subtype 3. Antibodies and aptamers that selectively bind to an epitope in the extracellular loop between transmembrane domains two and three of sphingosine-1-phosphate receptor subtype 3 are provided.
    Type: Application
    Filed: February 24, 2009
    Publication date: September 10, 2009
    Applicant: Expression Drug Designs, LLC
    Inventors: Deron R. Herr, Greg L. Harris